A review of current models for initiating injectable therapy for people with type 2 diabetes in primary care

Arti Appannah; Toni Rice; Rajna Ogrin

doi:10.1016/j.jcte.2017.05.003

A review of current models for initiating injectable therapy for people with type 2 diabetes in primary care

J Clin Transl Endocrinol. 2017 May 22:8:54-61. doi: 10.1016/j.jcte.2017.05.003. eCollection 2017 Jun.

Authors

Arti Appannah¹, Toni Rice¹, Rajna Ogrin^{1

2

3}

Affiliations

¹ RDNS Institute, Melbourne, Australia.
² University of Western Ontario, Canada.
³ Austin Health, Melbourne, Australia.

Abstract

Aims: To systematically identify and describe models of injectable therapy initiation for people with type 2 diabetes mellitus (T2DM) in primary care.

Methods: Eight electronic databases and the grey literature were searched. Studies examining models of injectable therapy initiation for adults with T2DM in primary care settings were included.

Results: Successful models included: 1) Nurse-led one-to-one approach; 2) Nurse-led group sessions; and 3) Providing education to GPs and nurses.

Conclusions: Few robust studies were found. Studied models were mainly in general practices, with limited evidence documented about starting people with T2DM on an injectable in the home setting.

Keywords: Injectable therapy; Insulin initiation; Nurse-led models of care; Primary care; Type two diabetes.

Publication types

Review